🇺🇸 FDA
Patent

US 10179783

Tetrahydropyridopyrazines as modulators of GPR6

granted A61PA61P25/00A61P25/16

Quick answer

US patent 10179783 (Tetrahydropyridopyrazines as modulators of GPR6) held by Takeda Pharmaceutical Company Limited expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P25/00, A61P25/16, A61P25/18, A61P25/24